Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TS1-ASO in Pediatric Timothy Syndrome Type 1
NCT07600658Phase 2Not yet recruiting
- Sponsor
- Stanford University
- Start
- Sep 2026
- Primary completion
- Dec 2029
- Modality
- Modified DNA Oligonucleotides, Single-strand DNA, Antisense Oligonucleotides (ASOs)
- Countries
- 1
01
Overview
A Phase 2 trial of TS1-ASO in Timothy syndrome, sponsored by Stanford University. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
TS1-ASO
03
Conditions
Timothy syndrome
Beyond the preview
Go deeper on NCT07600658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07600658.